Hanxi Hou

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-1951-3522

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Preclinical efficacy of CDK7 inhibitor–based combinations against myeloproliferative neoplasms transformed to AML”.

Preclinical efficacy of CDK7 inhibitor–based combinations against myeloproliferative neoplasms transformed to AML

Blood(2024)10.1182/blood.2024026388

N/A

0.395DataRank · unranked

10 citations

Christopher P. Mill, Prithviraj Bose, Lucia Masárová, Naveen Pemmaraju, Andrew Dunbar +18 more

Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM)

Blood Cancer Journal(2024)10.1038/s41408-024-00981-4

N/A

0.287DataRank · unranked

4 citations

Warren Fiskus, Courtney D. DiNardo, Patrick K. Reville, John A. Davis, Christine Birdwell +10 more

Preclinical efficacy of tasquinimod-based combinations in advanced myeloproliferative neoplasms in blastic phase

Blood Advances(2025)10.1182/bloodadvances.2025016898

N/A

0.262DataRank · unranked

4 citations

Lucia Masárová, Christopher P. Mill, Christine Birdwell, Kaberi Das, Hanxi Hou +16 more

BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor

Blood(2024)10.1182/blood.2023022832

N/A

0DataRank · unranked

42 citations

Jessica Piel, Michael P. Collins, Murphy Hentemann, Branko Cuglievan, Christopher P. Mill +21 more

Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes

Journal of Autoimmunity(2020)10.1016/j.jaut.2020.102543

N/A

0DataRank · unranked

19 citations

Erlinda Concepcion, Hanxi Hou, Hanane Arib, Mihaly Mezei, Roman Osman +2 more

BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML

Leukemia(2025)10.1038/s41375-025-02842-w

N/A

0DataRank · unranked

2 citations

Warren Fiskus, Christopher P. Mill, Tapan M. Kadia, Naval Daver, Courtney D. DiNardo +13 more

Superior preclinical efficacy of co-treatment with BRG1/BRM and FLT3 inhibitor against AML cells with FLT3 mutations

Blood Cancer Journal(2025)10.1038/s41408-025-01251-7

N/A

0DataRank · unranked

1 citations

Christopher P. Mill, Jessica Piel, Mike Collins, Murphy Hentemann, Branko Cuglievan +18 more